Abstract
With the recent boom in human sensing, the push to incorporate human mobility tracking with epidemic modeling highlights the lack of groundwork at the meso-scale (e.g., city-level) for both contact tracing and transmission dynamics. Although GPS data has been used to study city-level outbreaks, current approaches fail to capture the path of infection at the individual level. Consequently, in this paper, we extend the usefulness of epidemics prediction from estimating the size of an outbreak at the population level to estimating the individuals who may likely get infected within a finite period of time. To this end, we propose a network-based method to first build and then prune the dynamic contact networks for recurring interactions; these networks can serve as the backbone topology for mechanistic epidemics modeling. We test our method using Foursquare’s Points of Interest (POI) smart-phone geolocation data from over 1.3 million devices and show that we can recreate the COVID-19 infection curves for two major (yet very different) US cities (i.e., Austin and New York City) while maintaining the granularity of individual transmissions and reducing model uncertainty. Our method provides a foundation for building a disease prediction framework at the meso-scale that can help both policy makers and individuals of their estimated state of health and help with pandemic planning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding source supported this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There is no patient data included in this research, only anonymized mobility GPS data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
radum{at}utexas.edu, jdrake{at}tacc.utexas.edu, ravi.srinivasan{at}utexas.edu
Data Availability
Data is privately sourced from FourSquare made available through AWS.